EcoDrugPlus

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSAOCG00000023399
Gene Symbol: LOC111566706
2 Cross references
225 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2b-Like

Ensembl ID : ENSAOCG00000014002
Gene Symbol: LOC111581800
3 Cross references
256 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSAOCG00000019883
Gene Symbol: LOC111569795
2 Cross references
227 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 1-Like

Ensembl ID : ENSAOCG00000010207
Gene Symbol: LOC111575861
2 Cross references
246 Possible Orthologues:

Glutaminase

Ensembl ID : ENSAOCG00000023928
Gene Symbol: GLS
4 Cross references
225 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSAOCG00000023785
Gene Symbol: LOC111574163
3 Cross references
236 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSAOCG00000010716
Gene Symbol: GSK3B
3 Cross references
208 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSAOCG00000003929
Gene Symbol: LOC111563193
3 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSAOCG00000013659
Gene Symbol: LOC111572397
3 Cross references
187 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSAOCG00000023972
Gene Symbol: LOC111587971
2 Cross references
191 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSAOCG00000013694
Gene Symbol: GHRHR
4 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSAOCG00000020613
Gene Symbol: LOC111569997
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).